Aerolase Rating from Providers: 4.3 out of 5
Aerolase Rating from Patients: 4.0 out of 5

Want to see how MBC reviews are calculated? Click here.

Review Summary

Aerolase offers laser technologies used for concerns ranging from acne, redness, and pigmentation to skin texture, fine lines, wrinkles, and resurfacing.

The submitted reviews discuss two distinct technologies: LightPod Neo, a 1064 nm Nd laser, and LightPod Era, a 2940 nm Er resurfacing laser.

The distinction matters because the devices have different treatment mechanisms, applications, and recovery expectations.

The most interesting finding is that patients generally appreciate Aerolase treatments, but the amount of improvement—and the number of sessions required—can vary considerably.

Some patients reported meaningful improvements in acne, pigmentation, redness, and broken capillaries. Others described subtle changes that required several sessions, while one patient reported no noticeable improvement after five treatments.

Providers were largely enthusiastic about the versatility of Aerolase technology, particularly the ability to address different skin concerns and tailor treatments to patient needs.

However, much of the provider feedback came from promotional material rather than detailed independent clinical evaluations.

Overall, Aerolase receives favorable sentiment, but the reviews suggest that patient selection, device choice, and realistic treatment expectations are essential.

Provider Praise

(Industry sentiment from Social Media, Facebook, Instagram & Forums)

Provider sentiment was strongly positive.

Providers highlighted several applications across Aerolase technologies:

• Acne treatment and management
• Improvement in visible redness
• Reduction in the appearance of pigmentation
• Skin resurfacing and texture improvement
• Fine lines and wrinkles
• Treatment of certain types of scarring
• Customizable treatment parameters
• Options for patients seeking limited downtime

For LightPod Neo, providers emphasized the ability to address acne and redness while offering treatments with minimal recovery.

One provider described Neo as particularly useful for a patient experiencing stress-related chin acne who could not accommodate downtime.

Another described Aerolase as effective for acne, hyperpigmentation, and uneven texture, while appreciating the ability to combine it with other treatments.

For LightPod Era, providers focused more heavily on resurfacing.

They described its 2940 nm Er technology as a way to precisely treat superficial skin layers and improve the appearance of fine lines, texture irregularities, and certain scars.

One firsthand account of an Era Elite treatment reported satisfaction with the results despite mild redness, burning, peeling, and swelling during recovery.

Together, these comments suggest that one of Aerolase’s strengths is the range of concerns addressed across its different platforms.

Provider Complaints

(Industry sentiment from Social Media, Facebook, Instagram & Forums)

There were no explicitly negative provider comments in the submitted dataset, although two were classified as Mixed.

The most meaningful concerns centered on treatment expectations and recovery.

One provider described Era as involving substantially less discomfort than some other resurfacing procedures, while another noted that Era may require recovery depending on treatment depth.

This is an important distinction because the minimal-downtime reputation associated with Neo should not automatically be applied to Era.

The dataset also contains broad promotional claims about safety, comfort, and treatment effectiveness.

These claims were not accompanied by enough detailed clinical information to evaluate their accuracy across different patients and treatment settings.

The primary limitation of the provider feedback is not widespread dissatisfaction. It is the shortage of independent, detailed clinical experience.

Patient Reviews 

(Industry sentiment from Reddit, Facebook, Instagram & Forums)

Patient Reviews: 4.0 out of 5 stars

What Patients Are Saying

Patient feedback was generally favorable, particularly among people receiving treatments for acne, pigmentation, and redness.

One patient reported completing approximately ten Aerolase treatments and considered them worthwhile.

Their primary concern was acne, but they also appreciated improvements in redness and broken capillaries.

Another patient reported that three Aerolase treatments were gradually fading dermal pigmentation.

A separate patient specifically mentioned improvements in melasma and acne scars, although the exact Aerolase platform was not identified.

These experiences suggest that some patients are satisfied with gradual improvements across multiple skin concerns.

However, the strongest negative experience involved a patient who completed five LightPod Neo treatments on the face, neck, and décolletage without noticing meaningful results.

The patient had expected improvements in several concerns and expressed disappointment after completing the treatment series.

This account was reclassified from Mixed to Negative in the sentiment audit because the patient reported no meaningful benefit despite multiple paid treatments.

Cost Breakdown

The submitted dataset does not contain verified manufacturer equipment acquisition pricing for Aerolase LightPod Neo or LightPod Era.

It also does not provide reliable patient treatment prices or enough information to calculate average treatment-series costs.

However, the patient reviews illustrate why the total number of treatments matters financially.

One patient reported satisfaction after approximately ten treatments.

Another described improvement after three treatments.

A third reported no noticeable benefit after five paid treatments.

For patients, this creates a meaningful difference between the price of a single session and the total cost of achieving a satisfactory result.

For practices, the financial evaluation should be performed separately for each Aerolase platform.

LightPod Neo and LightPod Era address different clinical needs and should not automatically be assigned the same treatment pricing, patient volume expectations, or return-on-investment assumptions.

Final Verdict

Aerolase earns favorable sentiment from both providers and patients, particularly for its range of applications across acne, pigmentation, redness, and skin resurfacing.

Providers appreciate the treatment flexibility offered across its technologies, while several patients reported worthwhile improvements after completing multiple sessions.

However, the reviews also reveal a meaningful limitation.

Positive sentiment toward Aerolase as a brand does not guarantee that every patient will respond equally—or that every Aerolase device is appropriate for the same concern.

Some patients reported gradual improvements. Others needed extensive treatment series. One patient experienced no meaningful benefit after five Neo sessions.

The distinction between Neo and Era is equally important when discussing downtime.

Best suited for:

• Practices treating a range of aesthetic skin concerns
• Patients seeking treatment for acne, redness, or pigmentation with an appropriately selected platform
• Patients considering professional skin resurfacing with Era
• Patients comfortable with gradual improvement over a treatment series
• Providers experienced in matching laser technology to patient needs

Not ideal for:

• Patients expecting dramatic improvement after a single treatment
• Patients unwilling to complete a recommended treatment series
• Patients expecting every Aerolase treatment to have zero downtime
• Practices that do not distinguish between the applications of Neo and Era
• Patients seeking guaranteed results without variability

Overall assessment: Aerolase receives a 4.3 provider rating and 4.0 patient rating based on the submitted, quality-adjusted sentiment.

The strongest evidence comes from patients reporting improvements in acne, pigmentation, and redness, alongside providers describing the versatility of the different platforms.

However, the promotional nature of much of the feedback and the variability in patient outcomes prevent a stronger endorsement.

Ultimately, the most important question is not simply whether Aerolase is effective. It is which Aerolase technology is being used, what the patient is trying to correct, and whether the expected results justify the treatment commitment.